Standing at a clear podium at the front of a dark blue stage, Steve Rusckowski, Quest Diagnostics Chairman, President and CEO, addresses the American Clinical Laboratory Association (ACLA) 2017 annual meeting in Washington, D.C.

‘An Incredible Time to be in Health Care’

Action

Steve Rusckowski, Quest Diagnostics Chairman, President and CEO, opens the annual American Clinical Laboratory Association (ACLA) meeting in Washington, D.C.

Quest Diagnostics Chairman, President and CEO Steve Rusckowski discusses health care issues with Fox Business Network's Maria Bartiromo

Quest CEO Discusses ACA & More with Fox, Bloomberg

Action

Quest’s Steve Rusckowski tapped to discuss national health care issues

Quest Joins Major Labs to Lead HCV Diagnostics Discussion

Action

Quest’s Rick L. Pesano, M.D., Ph.D., recently joined thought leaders at the CDC Hepatitis C Diagnostics Summit.

Quest Achieves 2016 CEO Cancer Gold Standard™ Accreditation

Action

We’re happy to announce that the CEO Roundtable on Cancer recently awarded Quest Diagnostics CEO Cancer Gold Standard re-accreditation for maintaining a strong commitment to the health and well-being of our employees and their families.

Quest Recognized for Green Efforts

Action

As a company, Quest Diagnostics is regularly recognized for business performance, but we are equally, if not more proud that our sustainability efforts also receive notice.

Quest Marks 16 Years on Fortune 500

Action

For the 16th consecutive year, Quest Diagnostics is honored to appear on the Fortune 500. The 2016 list finds us at #358, up 17 spots from the previous year, and it’s a recognition of which we’re quite proud.

Quest Joins White House Hepatitis Testing Day Event

Action

We’re proud that Rick Pesano, MD, PhD, Quest Diagnostics Vice President, Research and Development, and Medical Director, Infectious Diseases, was invited to take part in “Responding to Viral Hepatitis in the US,” yesterday’s 2016 National Hepatitis Testing Day program at the White House.

National Drug Take-Back Day

Action

The Drug Enforcement Administration (DEA) is coordinating a National Drug Take-Back Day event on Saturday, April 30, 2016 (10 a.m.- 2 p.m.).